Long-term cardiac sequelae of Kawasaki disease

Area of Science:

• Pediatric Cardiology
• Immunology
• Vascular Biology

Background:

• Kawasaki disease is a primary cause of acquired heart disease in childhood.
• Intravenous gamma globulin is the standard treatment, but coronary abnormalities persist in 2-4% of patients.
• Coronary artery abnormalities range from mild involvement to giant aneurysms, posing risks for stenosis and myocardial infarction.

Purpose of the Study:

• To outline the spectrum of coronary abnormalities following Kawasaki disease.
• To describe management strategies based on the severity of coronary involvement.
• To highlight the long-term implications and uncertainties of Kawasaki disease on cardiovascular health.

Main Methods:

• Review of clinical management guidelines for Kawasaki disease.
• Analysis of patient outcomes based on coronary artery status.
• Discussion of diagnostic and therapeutic approaches, including imaging and pharmacotherapy.

Main Results:

• Patients with giant aneurysms require aggressive anticoagulation, frequent follow-up with stress testing and angiography, and potentially coronary artery bypass grafting.
• Those with less severe coronary involvement are managed with antiplatelet therapy and less frequent noninvasive testing.
• Patients with normal echocardiograms post-acute phase receive no treatment, but long-term cardiovascular impact remains uncertain.

Conclusions:

• Management of Kawasaki disease-associated coronary abnormalities is stratified by severity.
• Long-term surveillance is crucial, especially considering potential adult-onset coronary artery disease.
• Further research is needed to understand the lifelong cardiovascular risks in affected individuals.